World Investment Advisors’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48M Hold
91,016
0.02% 574
2026
Q1
$1.48M Sell
91,016
-8,504
-9% -$142K 0.02% 585
2025
Q4
$1.67M Buy
99,520
+6,654
+7% +$112K 0.03% 525
2025
Q3
$1.44M Buy
+92,866
New +$1.27M 0.03% 477

Other funds holding HQL

World Investment Advisors's HQL Position: Q2 2026 in Review

World Investment Advisors held its abrdn Life Sciences Investors (HQL) position steady in Q2 2026 at 91,016 shares worth $1.48M. The position accounts for 0.02% of the portfolio, ranked #574.

World Investment Advisors first reported a position in HQL in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.67M in Q4 2025. 83 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

  • World Investment Advisors held 91,016 shares of abrdn Life Sciences Investors worth $1.48M as of Q2 2026.
  • World Investment Advisors left its abrdn Life Sciences Investors share count unchanged in Q2 2026.
  • abrdn Life Sciences Investors made up 0.02% of World Investment Advisors's portfolio in Q2 2026, its #574 holding.
  • World Investment Advisors first reported a position in abrdn Life Sciences Investors in Q3 2025 and has held it in 4 quarters since.
  • World Investment Advisors's abrdn Life Sciences Investors position peaked at $1.67M in Q4 2025.
  • 83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on World Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.